Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 1, 2001Transplantation

A Randomized, Double-Blind Trial of Basiliximab Immunoprophylaxis Plus Triple Therapy in Kidney Transplant Recipients1,2

View Full Paper
Ask AI
Bookmark
Share

Authors

CPClaudio PonticelliLaboratoire AmpèreAYAlexander YussimVCV. CambiUniversity of Parma

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Ponticelli et al. (2001) studied this question.

synapsesocial.com/papers/6a82fb229ee9542cd6efdc45https://doi.org/10.1097/00007890-200110150-00014
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Increased Incidence of Lymphoproliferative Disorder after Immunosuppression with the Monoclonal Antibody OKT3 in Cardiac-Transplant Recipients1990 · 953 citations
  2. 2CLINICAL CORRELATES OF CHRONIC REJECTION IN PEDIATRIC RENAL TRANSPLANTATION1996 · 81 citations
  3. 3THE IMPACT OF ACUTE REJECTION EPISODES ON LONG-TERM GRAFT FUNCTION AND OUTCOME IN 1347 PRIMARY RENAL TRANSPLANTS TREATED BY 3 CYCLOSPORINE REGIMENS1993 · 267 citations
  4. 4Interleukin-2–Receptor Blockade with Daclizumab to Prevent Acute Rejection in Renal Transplantation1998 · 878 citations
  5. 5PROLONGED ACTION OF A CHIMERIC INTERLEUKIN-2 RECEPTOR (CD25) MONOCLONAL ANTIBODY USED IN CADAVERIC RENAL TRANSPLANTATION1995 · 184 citations